Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 R&D Investment Trends (2024)
5.2 mRNA Therapeutics/Platform Manufacturing Capacity, by Region (2024)
5.3 Spending on mRNA Raw Materials, by Source (Government, Biopharma, CDMOs), 2024
5.4 Pricing Trends of Key mRNA Raw Materials (2021–2024)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. mRNA Synthesis Raw Materials Market Segmentation by Type
7.1 Chapter Overview
7.2 Capping Agents
7.2.1 Capping Agents Market Trends Analysis (2021-2032)
7.2.2 Capping Agents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 CleanCap Reagents
7.2.3.1 CleanCap Reagents Market Trends Analysis (2021-2032)
7.2.3.2 CleanCap Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 ARCA (Anti-Reverse Cap Analog)
7.2.4.1 ARCA (Anti-Reverse Cap Analog) Market Trends Analysis (2021-2032)
7.2.4.2 ARCA (Anti-Reverse Cap Analog) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Others
7.2.5.1 Others Market Trends Analysis (2021-2032)
7.2.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Nucleotides
7.3.1 Nucleotides Market Trends Analysis (2021-2032)
7.3.2 Nucleotides Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Modified Nucleic Acids
7.3.3.1 Modified Nucleic Acids Market Trends Analysis (2021-2032)
7.3.3.2 Modified Nucleic Acids Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.3 N1-methylpseudouridine-triphosphate
7.3.3.3.1 N1-methylpseudouridine-triphosphate Market Trends Analysis (2021-2032)
7.3.3.3.2 N1-methylpseudouridine-triphosphate Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.4 5-Methylcytidine triphosphate (5mCTP)
7.3.3.4.1 5-Methylcytidine triphosphate (5mCTP) Market Trends Analysis (2021-2032)
7.3.3.4.2 5-Methylcytidine triphosphate (5mCTP) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3.5 Others
7.3.3.5.1 Others Market Trends Analysis (2021-2032)
7.3.3.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Natural Nucleic Acids
7.3.4.1 Natural Nucleic Acids Market Trends Analysis (2021-2032)
7.3.4.2 Natural Nucleic Acids Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.3 Adenine
7.3.4.3.1 Adenine Market Trends Analysis (2021-2032)
7.3.4.3.2 Adenine Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.4 Guanine
7.3.4.4.1 Guanine Market Trends Analysis (2021-2032)
7.3.4.4.2 Guanine Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.5 Cytosine
7.3.4.5.1 Cytosine Market Trends Analysis (2021-2032)
7.3.4.5.2 Cytosine Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4.6 Uracil
7.3.4.6.1 Uracil Market Trends Analysis (2021-2032)
7.3.4.6.2 Uracil Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Plasmid DNA
7.4.1 Plasmid DNA Market Trends Analysis (2021-2032)
7.4.2 Plasmid DNA Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Enzymes
7.5.1 Enzymes Market Trends Analysis (2021-2032)
7.5.2 Enzymes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.3 Polymerase
7.5.3.1 Polymerase Market Trends Analysis (2021-2032)
7.5.3.2 Polymerase Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.4 RNase Inhibitor
7.5.4.1 RNase Inhibitor Market Trends Analysis (2021-2032)
7.5.4.2 RNase Inhibitor Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.5 DNase
7.5.5.1 DNase Market Trends Analysis (2021-2032)
7.5.5.2 DNase Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5.6 Others
7.5.6.1 Others Market Trends Analysis (2021-2032)
7.5.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.6.1 Others Market Trends Analysis (2021-2032)
7.6.2 Squamous Cell Carcinoma of the Head and Neck Market Size Estimates and Forecasts to 2032 (USD Billion)
8. mRNA Synthesis Raw Materials Market Segmentation By Application
8.1 Chapter Overview
8.2 Vaccine Production
8.2.1 Vaccine Production Market Trend Analysis (2021-2032)
8.2.2 Vaccine Production Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Therapeutics Production
8.3.1 Therapeutics Production Market Trends Analysis (2021-2032)
8.3.2 Therapeutics Production Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2021-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. mRNA Synthesis Raw Materials Market Segmentation By End Use
9.1 Chapter Overview
9.2 Biopharmaceutical & Pharmaceutical Companies
9.2.1 Biopharmaceutical & Pharmaceutical Companies Market Trends Analysis (2021-2032)
9.2.2 Biopharmaceutical & Pharmaceutical Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 CROs & CMOs
9.3.1 CROs & CMOs Market Trends Analysis (2021-2032)
9.3.2 CROs & CMOs Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Academic & Research Institutes
9.4.1 Academic & Research Institutes Market Trends Analysis (2021-2032)
9.4.2 Academic & Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.4 North America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.5 North America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.6.2 USA mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.6.3 USA mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.7.2 Canada mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.7.3 Canada mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.2.8.2 Mexico mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.8.3 Mexico mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.4 Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.5 Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.1.6.2 Germany mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.1.6.3 Germany mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.7.2 France mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.7.3 France mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.8.2 UK mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.8.3 UK mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.9.2 Italy mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.9.3 Italy mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.10.2 Spain mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.10.3 Spain mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.12.3 Poland mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.12.3 Poland mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.13.2 Turkey mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.13.3 Turkey mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.4 Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.5 Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.6.2 China mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.6.3 China mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.7.2 India mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.7.3 India mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.8.2 Japan mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.8.3 Japan mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.9.2 South Korea mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.9.3 South Korea mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.10.2 Singapore mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.10.3 Singapore mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.11.2 Australia mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.11.3 Australia mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.4 Middle East and Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.5 Middle East and Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.6.2 UAE mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.6.3 UAE mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.8.2 Qatar mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.8.3 Qatar mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.9 2 South Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
10.5.9 3 South Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.4 Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.5 Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.6.2 Brazil mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.6.3 Brazil mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.7.2 Argentina mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.7.3 Argentina mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, by Type (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America mRNA Synthesis Raw Materials Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
12. Company Profiles
12.1 Thermo Fisher Scientific
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Merck KGaA
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Cytiva
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 TriLink BioTechnologies
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 New England Biolabs
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 BioNTech
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Moderna
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 CureVac
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 GenScript
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 ST Pharm
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
